Interacting Drugs |
Sitagliptin and metformin vs ACE Inhibitors |
Security Level |
|
Mechanism |
ACE Inhibitors: DPP-IV Inhibitors may enhance the adverse/toxic effect of ACE Inhibitors. Specifically, the risk of angioedema may be increased. |
Management |
Monitor therapy |
Sitagliptin and metformin vs ACE Inhibitors
Post Review about Sitagliptin and metformin vs ACE Inhibitors Click here to cancel reply.
Other Interactions of Sitagliptin and metformin
Other Interactions of ACE Inhibitors
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.